Skip to main content
. Author manuscript; available in PMC: 2007 Sep 25.
Published in final edited form as: Diabetes Care. 2005 Mar;28(3):527–532. doi: 10.2337/diacare.28.3.527

Table 3.

Trend Analysis of Significant Intervention Effects; ANCOVA Analyses Controlling for Baseline Measures

Outcome Measure Measurement Time* Experimental Group “Compressed” Control Group “Extended”
INTERVENTION ATTENDANCE INTERVENTION ATTENDANCE
Low Attendance High Attendance Low Attendance High Attendance Significance (p)
Madj** Madj** Madj** Madj** Intervention Attendance Intervention by attendance interaction
HbA1c 3-Month 11.6±3.1(33) 10.5±2.6(61) 11.8±3.8(43) 10.5±2.6(51) .71 <.001 .74
12-Month 10.8±3.5(21) 11.3±3.1(62) 11.3±3.0(37) 10.0±2.5(46) .30 .40 .05
Fasting
Blood Glucose
3-Month 175.2±57.9(33) 159.6±51.5(61) 195.8±65.4(43) 163.6±46.2(51) .09 <.001 .20
12-Month 181.1±75.7(21) 178.5±54.4(63) 183.8±76.0(37) 165.0±40.7(46) .15 .23 .45
Diabetes Knowledge 3-Month 15.2±2.8(32) 16.3±3.5(61) 15.8±3.0(43) 16.6±2.9(51) .51 .02 .67
12-Month 12.6±6.4(26) 15.0±5.1(67) 13.3±6.2(44) 15.7±5.5(50) .73 .007 .96
*

3-month measurement is evaluation of educational component of the intervention, controlling for baseline differences in outcome variable; 12-month measure is evaluation of support group component, controlling for 3-month differences in outcome variable

**

Madj = adjusted mean (based on baseline mean)